NOVOZYMES A/S SPONS.ADR 1
NOVOZYMES A/S SPONS.ADR 1
Depository Receipt · US6701081092 · A0YF6B (PINX)
Overview
No Price
19.12.2025 07:02
Current Prices from NOVOZYMES A/S SPONS.ADR 1
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
NZM.F
EUR
19.12.2025 07:02
53,00 EUR
1,00 EUR
+1,92 %
XDQU: Quotrix
Quotrix
NASNAS92.DUSD
EUR
19.12.2025 06:27
54,00 EUR
2,00 EUR
+3,85 %
XDUS: Düsseldorf
Düsseldorf
NASNAS92.DUSB
EUR
18.12.2025 18:31
53,00 EUR
1,50 EUR
+2,91 %
OTC: UTC
UTC
NVZMY
USD
08.12.2025 21:00
61,37 USD
-1,28 USD
-2,04 %
Company Profile for NOVOZYMES A/S SPONS.ADR 1 Depository Receipt
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
AI Analysis of NOVOZYMES A/S SPONS.ADR 1
Click any analysis below to get instant AI insights from finAgent

Company Data

Name NOVOZYMES A/S SPONS.ADR 1
Company Novozymes A/S
Website https://www.novozymes.com
Primary Exchange PINX Frankfurt
WKN A0YF6B
ISIN US6701081092
Asset Class Depository Receipt
Sector Basic Materials
Industry Chemicals - Specialty
CEO Ester Baiget
Market Capitalization 30 Mrd.
Country Denmark
Currency EUR
Employees 10,6 T
Address Krogshoejvej 36, 2880 Bagsvaerd
IPO Date 2010-01-20

Ticker Symbols

Name Symbol
Over The Counter NVZMY
Düsseldorf NASNAS92.DUSB
Frankfurt NZM.F
Quotrix NASNAS92.DUSD
More Shares
Investors who hold NOVOZYMES A/S SPONS.ADR 1 also have the following shares in their portfolio:
NED.WATERSCH 22/32 MTN
NED.WATERSCH 22/32 MTN Bond
Xybion Digital Inc.
Xybion Digital Inc. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025